G. Férir

发表

NICTABA and UDA, two GlcNAc-binding lectins with unique antiviral activity profiles

J. Balzarini, D. Schols, E. V. Van Damme, 2015, The Journal of antimicrobial chemotherapy.

Synergistic activity profile of griffithsin in combination with tenofovir, maraviroc and enfuvirtide against HIV-1 clade C.

K. Palmer, D. Schols, G. Férir, 2011, Virology.

Combinations of griffithsin with other carbohydrate-binding agents demonstrate superior activity against HIV Type 1, HIV Type 2, and selected carbohydrate-binding agent-resistant HIV Type 1 strains.

M. Swanson, D. Markovitz, J. Balzarini, 2012, AIDS Research and Human Retroviruses.

HIV-1 and Its Resistance to Peptidic Carbohydrate-Binding Agents (CBAs): An Overview

D. Schols, S. Gordts, G. Férir, 2014, Molecules.

The Low-Cost Compound Lignosulfonic Acid (LA) Exhibits Broad-Spectrum Anti-HIV and Anti-HSV Activity and Has Potential for Microbicidal Applications

S. Lebeer, D. Schols, M. Petrova, 2015, PloS one.

Antiviral treatment of chronic hepatitis B virus infections: the past, the present and the future

E. De Clercq, J. Neyts, S. Kaptein, 2008, Reviews in medical virology.

T‐cell receptor CDR3 size distribution analysis to evaluate specific T‐cell response to cancer vaccines

D. Elias, B. Escudier, G. Férir, 1997, International journal of cancer.

Antiviral Treatment of Chronic Hepatitis B Virus (HBV) Infections

E. De Clercq, J. Neyts, S. Kaptein, 2010, Viruses.

Synergistic anti-HIV-1 activity of griffithsin with tenofovir, maraviroc and enfuvirtide

K. Palmer, D. Schols, G. Férir, 2011, Retrovirology.

Broad anti-HIV activity of the Oscillatoria agardhii agglutinin homologue lectin family.

A. Gronenborn, D. Schols, S. Noppen, 2014, The Journal of antimicrobial chemotherapy.

The Lantibiotic Peptide Labyrinthopeptin A1 Demonstrates Broad Anti-HIV and Anti-HSV Activity with Potential for Microbicidal Applications

J. Vanderleyden, J. Balzarini, D. Schols, 2013, PloS one.

Microvirin, a Novel α(1,2)-Mannose-specific Lectin Isolated from Microcystis aeruginosa, Has Anti-HIV-1 Activity Comparable with That of Cyanovirin-N but a Much Higher Safety Profile*

E. Dittmann, J. Balzarini, D. Schols, 2010, The Journal of Biological Chemistry.

Griffithsin, Alone and Combined with All Classes of Antiretroviral Drugs, Potently Inhibits HIV Cell-Cell Transmission and Destruction of CD4+ T cells

K. Palmer, D. Schols, G. Férir, 2012 .

Exposure of Raji / DC-SIGN cells to HIV-1 and subsequent cocultivation with CD 4 1 C 8166 cells in the presence of OAA and OPA

A. Gronenborn, D. Schols, S. Noppen, 2014 .

Actinohivin, a Broadly Neutralizing Prokaryotic Lectin, Inhibits HIV-1 Infection by Specifically Targeting High-Mannose-Type Glycans on the gp120 Envelope

K. Van Laethem, J. Balzarini, D. Schols, 2010, Antimicrobial Agents and Chemotherapy.

Feglymycin, a unique natural bacterial antibiotic peptide, inhibits HIV entry by targeting the viral envelope protein gp120.

D. Schols, K. François, R. Süssmuth, 2012, Virology.

Synergistic in vitro anti-HIV type 1 activity of tenofovir with carbohydrate-binding agents (CBAs).

E. Dittmann, M. Swanson, D. Markovitz, 2011, Antiviral research.